Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

Description

A randomized controlled trial of 1,500 women to assess whether treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) in pregnancy will result in a reduction in the rate of hypertensive disorders of pregnancy.

Conditions

Obstructive Sleep Apnea of Adult, Preeclampsia, Obstetrical Complications

Study Overview

Study Details

Study overview

A randomized controlled trial of 1,500 women to assess whether treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) in pregnancy will result in a reduction in the rate of hypertensive disorders of pregnancy.

A Randomized Trial of Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

Condition
Obstructive Sleep Apnea of Adult
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama - Birmingham, Birmingham, Alabama, United States, 35233

San Francisco

Regents of the University of California San Francisco, San Francisco, California, United States, 94143

Chicago

Northwestern University, Chicago, Illinois, United States, 60611

New York

Columbia University, New York, New York, United States, 10032

Chapel Hill

University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States, 27599

Cleveland

Case Western Reserve-Metro Health, Cleveland, Ohio, United States, 44109

Columbus

Ohio State University Hospital, Columbus, Ohio, United States, 43210

Philadelphia

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Pittsburgh

Magee Women's Hospital of UPMC, Pittsburgh, Pennsylvania, United States, 15213

Providence

Brown Univeristy, Providence, Rhode Island, United States, 02905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to

    Sexes Eligible for Study

    FEMALE

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    The George Washington University Biostatistics Center,

    Rebecca Clifton, PhD, PRINCIPAL_INVESTIGATOR, The George Washington University Biostatistics Center

    Monica Longo, MD, STUDY_DIRECTOR, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    Francesca Facco, MD, STUDY_CHAIR, Magee Women's Hospital of UPMC

    Study Record Dates

    2026-12-31